Faron Pharmaceuticals Oy (FARN) — Cash Flow-to-Debt Ratio

Latest as of June 2025: 0.00x

Faron Pharmaceuticals Oy (FARN) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2025, meaning its operating cash flow of GBX-5.21K could theoretically repay 0% of its total liabilities (GBX32.45 Million) in one year. See Faron Pharmaceuticals Oy (FARN) financial flexibility to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

0.00x
Operating CF / Total Liabilities

Operating Cash Flow

GBX-5.21K
GBX

Total Liabilities

GBX32.45 Million
GBX

Data as of

Jun 2025
Most recent filing

Faron Pharmaceuticals Oy Cash Flow-to-Debt Ratio (2012–2024)

Historical debt coverage capacity for Faron Pharmaceuticals Oy across 13 annual periods. For the full cash flow conversion analysis, see Faron Pharmaceuticals Oy (FARN) cash flow conversion.

Annual Cash Flow-to-Debt Ratio for Faron Pharmaceuticals Oy (2012–2024)

Year-by-year debt coverage analysis for Faron Pharmaceuticals Oy.

Year CF-to-Debt Ratio Operating CF (GBX) Total Liabilities YoY Change
2024 -1.03x GBX-22.97 Million GBX22.28 Million ▼ -9.9%
2023 -0.94x GBX-23.81 Million GBX25.38 Million ▲ +7.2%
2022 -1.01x GBX-22.99 Million GBX22.75 Million ▲ +53.3%
2021 -2.16x GBX-22.22 Million GBX10.26 Million ▼ -26.5%
2020 -1.71x GBX-17.48 Million GBX10.22 Million ▼ -27.7%
2019 -1.34x GBX-11.52 Million GBX8.60 Million ▼ -49734.5%
2018 0.00x GBX-20.52K GBX7.63 Million ▲ +99.9%
2017 -1.81x GBX-18.36 Million GBX10.14 Million ▼ -37.2%
2016 -1.32x GBX-8.45 Million GBX6.40 Million ▲ +32.7%
2015 -1.96x GBX-7.15 Million GBX3.64 Million ▼ -1590.8%
2014 -0.12x GBX-389.00K GBX3.35 Million ▲ +51.9%
2013 -0.24x GBX-768.00K GBX3.19 Million ▲ +70.5%
2012 -0.82x GBX-2.27 Million GBX2.77 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.